Logo

Anti-VEGF Market Size, Share, and Growth Forecast 2026 - 2033

Anti-VEGF Market by Drug Type (Ranibizumab, Aflibercept, Bevacizumab, Brolucizumab, Faricimab, Others), by Indication (Age-Related Macular Degeneration (AMD), Diabetic Macular Edema (DME), Diabetic Retinopathy (DR), Retinal Vein Occlusion (RVO), Others), End-user (Hospitals, Ophthalmology Clinics, Ambulatory Surgical Centers (ASCs), Specialty Cancer Centers, Others), and Regional Analysis, 2026-2033

ID: PMRREP33422
Calendar

August 2026

190 Pages

Author : Pravin Rewale

Healthcare
  1. Executive Summary
    1. Global Anti-VEGF Market Snapshot 2026 and 2033
    2. Market Opportunity Assessment, 2026-2033, US$ Bn
    3. Key Market Trends
    4. Industry Developments and Key Market Events
    5. Demand Side and Supply Side Analysis
    6. PMR Analysis and Recommendations
  2. Market Overview
    1. Market Scope and Definitions
    2. Market Dynamics
      1. Driver
      2. Restraint
      3. Opportunities
      4. Trends
    3. Macro-Economic Factors
      1. Global Sectorial Outlook
      2. Global GDP Growth Outlook
    4. Forecast Factors – Relevance and Impact
    5. COVID-19 Impact Assessment
  3. Value Added Insights
    1. Value Chain analysis
    2. Key Market Players
    3. Product Adoption Analysis
    4. Key Promotional Strategies by key players
    5. PESTLE Analysis
    6. Porter's Five Forces Analysis
    7. Regulatory and Technology Landscape
  4. Price Trend Analysis, 2025
    1. Region-wise Price Analysis
    2. Price by Segments
    3. Price Impact Factors
  5. Global Anti-VEGF Market Outlook: Historical (2020 – 2025) and Forecast (2026 – 2033)
    1. Key Highlights
    2. Global Anti-VEGF Market Outlook: Drug Type
      1. Introduction/Key Findings
      2. Historical Market Size (US$ Bn) Analysis by Drug Type, 2020-2025
      3. Current Market Size (US$ Bn) Forecast, by Drug Type, 2026-2033
        1. Ranibizumab
        2. Aflibercept
        3. Bevacizumab
        4. Brolucizumab
        5. Faricimab
        6. Others
      4. Market Attractiveness Analysis: Drug Type
    3. Global Anti-VEGF Market Outlook: Indication
      1. Introduction/Key Findings
      2. Historical Market Size (US$ Bn) Analysis by Indication, 2020-2025
      3. Current Market Size (US$ Bn) Forecast, by Indication, 2026-2033
        1. Age-Related Macular Degeneration (AMD)
        2. Diabetic Macular Edema (DME)
        3. Diabetic Retinopathy (DR)
        4. Retinal Vein Occlusion (RVO)
        5. Others
      4. Market Attractiveness Analysis: Indication
    4. Global Anti-VEGF Market Outlook: End User
      1. Introduction/Key Findings
      2. Historical Market Size (US$ Bn) Analysis by End User, 2020-2025
      3. Current Market Size (US$ Bn) Forecast, by End User, 2026-2033
        1. Hospitals
        2. Ophthalmology Clinics
        3. Ambulatory Surgical Centers (ASCs)
        4. Specialty Cancer Centers
        5. Others
      4. Market Attractiveness Analysis: End User
  6. Global Anti-VEGF Market Outlook: Region
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis by Region, 2020-2025
    3. Current Market Size (US$ Bn) Forecast, by Region, 2026-2033
      1. North America
      2. Europe
      3. East Asia
      4. South Asia & Oceania
      5. Latin America
      6. Middle East & Africa
    4. Market Attractiveness Analysis: Region
  7. North America Anti-VEGF Market Outlook: Historical (2020 – 2025) and Forecast (2026 – 2033)
    1. Key Highlights
    2. Pricing Analysis
    3. North America Market Size (US$ Bn) Forecast, by Country, 2026-2033
      1. U.S.
      2. Canada
    4. North America Market Size (US$ Bn) Forecast, by Drug Type, 2026-2033
      1. Ranibizumab
      2. Aflibercept
      3. Bevacizumab
      4. Brolucizumab
      5. Faricimab
      6. Others
    5. North America Market Size (US$ Bn) Forecast, by Indication, 2026-2033
      1. Age-Related Macular Degeneration (AMD)
      2. Diabetic Macular Edema (DME)
      3. Diabetic Retinopathy (DR)
      4. Retinal Vein Occlusion (RVO)
      5. Others
    6. North America Market Size (US$ Bn) Forecast, by End User, 2026-2033
      1. Hospitals
      2. Ophthalmology Clinics
      3. Ambulatory Surgical Centers (ASCs)
      4. Specialty Cancer Centers
      5. Others
  8. Europe Anti-VEGF Market Outlook: Historical (2020 – 2025) and Forecast (2026 – 2033)
    1. Key Highlights
    2. Pricing Analysis
    3. Europe Market Size (US$ Bn) Forecast, by Country, 2026-2033
      1. Germany
      2. Italy
      3. France
      4. U.K.
      5. Spain
      6. Russia
      7. Rest of Europe
    4. Europe Market Size (US$ Bn) Forecast, by Drug Type, 2026-2033
      1. Ranibizumab
      2. Aflibercept
      3. Bevacizumab
      4. Brolucizumab
      5. Faricimab
      6. Others
    5. Europe Market Size (US$ Bn) Forecast, by Indication, 2026-2033
      1. Age-Related Macular Degeneration (AMD)
      2. Diabetic Macular Edema (DME)
      3. Diabetic Retinopathy (DR)
      4. Retinal Vein Occlusion (RVO)
      5. Others
    6. Europe Market Size (US$ Bn) Forecast, by End User, 2026-2033
      1. Hospitals
      2. Ophthalmology Clinics
      3. Ambulatory Surgical Centers (ASCs)
      4. Specialty Cancer Centers
      5. Others
  9. East Asia Anti-VEGF Market Outlook: Historical (2020 – 2025) and Forecast (2026 – 2033)
    1. Key Highlights
    2. Pricing Analysis
    3. East Asia Market Size (US$ Bn) Forecast, by Country, 2026-2033
      1. China
      2. Japan
      3. South Korea
    4. East Asia Market Size (US$ Bn) Forecast, by Drug Type, 2026-2033
      1. Ranibizumab
      2. Aflibercept
      3. Bevacizumab
      4. Brolucizumab
      5. Faricimab
      6. Others
    5. East Asia Market Size (US$ Bn) Forecast, by Indication, 2026-2033
      1. Age-Related Macular Degeneration (AMD)
      2. Diabetic Macular Edema (DME)
      3. Diabetic Retinopathy (DR)
      4. Retinal Vein Occlusion (RVO)
      5. Others
    6. East Asia Market Size (US$ Bn) Forecast, by End User, 2026-2033
      1. Hospitals
      2. Ophthalmology Clinics
      3. Ambulatory Surgical Centers (ASCs)
      4. Specialty Cancer Centers
      5. Others
  10. South Asia & Oceania Anti-VEGF Market Outlook: Historical (2020 – 2025) and Forecast (2026 – 2033)
    1. Key Highlights
    2. Pricing Analysis
    3. South Asia & Oceania Market Size (US$ Bn) Forecast, by Country, 2026-2033
      1. India
      2. Southeast Asia
      3. ANZ
      4. Rest of SAO
    4. South Asia & Oceania Market Size (US$ Bn) Forecast, by Drug Type, 2026-2033
      1. Ranibizumab
      2. Aflibercept
      3. Bevacizumab
      4. Brolucizumab
      5. Faricimab
      6. Others
    5. South Asia & Oceania Market Size (US$ Bn) Forecast, by Indication, 2026-2033
      1. Age-Related Macular Degeneration (AMD)
      2. Diabetic Macular Edema (DME)
      3. Diabetic Retinopathy (DR)
      4. Retinal Vein Occlusion (RVO)
      5. Others
    6. South Asia & Oceania Market Size (US$ Bn) Forecast, by End User, 2026-2033
      1. Hospitals
      2. Ophthalmology Clinics
      3. Ambulatory Surgical Centers (ASCs)
      4. Specialty Cancer Centers
      5. Others
  11. Latin America Anti-VEGF Market Outlook: Historical (2020 – 2025) and Forecast (2026 – 2033)
    1. Key Highlights
    2. Pricing Analysis
    3. Latin America Market Size (US$ Bn) Forecast, by Country, 2026-2033
      1. Brazil
      2. Mexico
      3. Rest of LATAM
    4. Latin America Market Size (US$ Bn) Forecast, by Drug Type, 2026-2033
      1. Ranibizumab
      2. Aflibercept
      3. Bevacizumab
      4. Brolucizumab
      5. Faricimab
      6. Others
    5. Latin America Market Size (US$ Bn) Forecast, by Indication, 2026-2033
      1. Age-Related Macular Degeneration (AMD)
      2. Diabetic Macular Edema (DME)
      3. Diabetic Retinopathy (DR)
      4. Retinal Vein Occlusion (RVO)
      5. Others
    6. Latin America Market Size (US$ Bn) Forecast, by End User, 2026-2033
      1. Hospitals
      2. Ophthalmology Clinics
      3. Ambulatory Surgical Centers (ASCs)
      4. Specialty Cancer Centers
      5. Others
  12. Middle East & Africa Anti-VEGF Market Outlook: Historical (2020 – 2025) and Forecast (2026 – 2033)
    1. Key Highlights
    2. Pricing Analysis
    3. Middle East & Africa Market Size (US$ Bn) Forecast, by Country, 2026-2033
      1. GCC Countries
      2. South Africa
      3. Northern Africa
      4. Rest of MEA
    4. Middle East & Africa Market Size (US$ Bn) Forecast, by Drug Type, 2026-2033
      1. Ranibizumab
      2. Aflibercept
      3. Bevacizumab
      4. Brolucizumab
      5. Faricimab
      6. Others
    5. Middle East & Africa Market Size (US$ Bn) Forecast, by Indication, 2026-2033
      1. Age-Related Macular Degeneration (AMD)
      2. Diabetic Macular Edema (DME)
      3. Diabetic Retinopathy (DR)
      4. Retinal Vein Occlusion (RVO)
      5. Others
    6. Middle East & Africa Market Size (US$ Bn) Forecast, by End User, 2026-2033
      1. Hospitals
      2. Ophthalmology Clinics
      3. Ambulatory Surgical Centers (ASCs)
      4. Specialty Cancer Centers
      5. Others
  13. Competition Landscape
    1. Market Share Analysis, 2025
    2. Market Structure
      1. Competition Intensity Mapping
      2. Competition Dashboard
    3. Company Profiles
      1. Pfizer Inc.
        1. Company Overview
        2. Product Portfolio/Offerings
        3. Key Financials
        4. SWOT Analysis
        5. Company Strategy and Key Developments
      2. Bayer AG
      3. Novartis AG
      4. Sanofi
      5. Exelixis, Inc.
      6. Eisai Co., Ltd.
      7. Amgen Inc.
      8. F. Hoffmann-La Roche Ltd
      9. Eli Lilly and Company
      10. Amneal Pharmaceuticals, Inc.
      11. Jiangsu Hengrui Pharmaceuticals Co., Ltd.
      12. Takeda Pharmaceutical Company Limited
      13. Sino Biopharmaceutical Limited
      14. HUTCHMED (China) Limited
      15. Regeneron Pharmaceuticals, Inc.
      16. Others
  14. Appendix
    1. Research Methodology
    2. Research Assumptions
    3. Acronyms and Abbreviations
Emailsales@persistencemarketresearch.com
UK

Corporate Office

Persistence Research & Consultancy Services Limited

Company Number : 15310893

Second Floor, 150 Fleet Street,London, EC4A 2DQ.

+44 203-837-5656
USA

Regional Office

Persistence Market Research

108 W 39th Street, Ste 1006,PMB2219, New York, NY 10018

+1 646-878-6329
India

Global Research centre

Persistence Market Research Private Limited

CIN : U74900PN2014PTC153163

6th Floor, Teerth Technospace, Teerth Realties, Office No. B- 604, Baner, Pune, Maharashtra 411045

+91 906 779 3500SIN : +65 3138 9498
Quick Links
CareersTerms & ConditionsReturn PolicyMarket Research Report
Customer FAQ’sPrivacy PolicySitemap

Copyright © 2026 Persistence Market Research. All Rights Reserved

Connect With Us -